Literature DB >> 16327439

Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage.

Patrick Adam1, Tiemo Katzenberger, Miriam Eifert, M Michaela Ott, Andreas Rosenwald, Hans Konrad Müller-Hermelink, German Ott.   

Abstract

Follicular lymphoma (FL) typically presents as a systemic disease (stages III/IV). We repeatedly observed in cases with conserved reactive follicle structures (so-called partial infiltration) an association with a limited clinical stage (I/II). In this study, we analyzed 53 lymph node biopsies of FL with conserved reactive follicle structures. In 44 cases (83%) of the patients with partial infiltration, a limited stage of disease (Ann Arbor stage I/II) was found, whereas only 9 of 53 cases (17%) suffered from a systemic disease. In those cases with at least one follicle totally spared by lymphoma, 95% of the patients (38 of 40 cases) presented with a limited stage (I/II) of disease, compared with only 20% (10 of 49 cases) in a control group with full-blown infiltration (P < 0.001). Analyzing systematically all 321 FL cases sent to the Reference Center Würzburg in the year 2001, reactive follicle remnants were detected in 34 of 321 (10.6%) cases with 26 of 34 (76%) tumors showing limited stage (I/II) disease, including all 18 cases with at least one totally spared follicle. Our results therefore show a clear association between the occurrence of preserved reactive follicles in FL and limited disease stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327439     DOI: 10.1097/01.pas.0000173233.29741.38

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

Review 2.  [Diagnostic spectrum of reactive lymph node changes].

Authors:  S Hartmann; S Kriener; M L Hansmann
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

3.  t(14;18)-positive B cells: is it seed or soil?

Authors:  Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-10-18       Impact factor: 22.113

Review 4.  [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

Authors:  S Hartmann; S Cogliatti; M-L Hansmann
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

Review 5.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

6.  Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.

Authors:  Janice M Spence; Andrew Abumoussa; John P Spence; W Richard Burack
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

7.  In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.

Authors:  Alejandra Carvajal-Cuenca; Luz F Sua; Nhora M Silva; Stefania Pittaluga; Cristina Royo; Joo Y Song; Rachel L Sargent; Blanca Espinet; Fina Climent; Samuel A Jacobs; Jan Delabie; Kikkeri N Naresh; Adam Bagg; Pierre Brousset; Roger A Warnke; Sergi Serrano; Nancy Lee Harris; Steven H Swerdlow; Elaine S Jaffe; Elías Campo
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

8.  [Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas].

Authors:  W Klapper; H H Wacker
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

Review 9.  [In situ lymphoma and other early stage malignant non-Hodgkin lymphomas].

Authors:  L Quintanilla-Martínez; P Adam; F Fend
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

10.  Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas.

Authors:  German Ott; Olga Balague-Ponz; Laurence de Leval; Daphne de Jong; Robert P Hasserjian; Kojo S J Elenitoba-Johnson
Journal:  J Hematop       Date:  2009-06-25       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.